Exact Mass: 314.1267

Exact Mass Matches: 314.1267

Found 165 metabolites which its exact mass value is equals to given mass value 314.1267, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

(R)-3-(METHYLAMINO)-1-PHENYLPROPANOLHYDROCHLORIDE

1-(2-Hydroxy-3-methylnaphthalen-1-yl)-3-methylnaphthalen-2-ol

C22H18O2 (314.1307)

3-[4-(3-Trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one

C15H17F3N2O2 (314.1242)

Methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate

Methyl 4-ethyl-6,7-dimethoxy-9H-pyrido[3,4-b]indole-3-carboxylic acid

C17H18N2O4 (314.1267)

Molinate

2-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-2,3-dihydro-1H-pyrazol-3-one

C13H14N8O2 (314.124)

Cyclopropyl-methoxycarbonyl metomidate

1-(Methoxycarbonyl)cyclopropyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid

C17H18N2O4 (314.1267)

D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018755 - GABA Agonists

N-Bicyclo[2.2.1]hept-5-en-2-yl-N-(3-cyano-4,6-dimethyl-2-oxo-1,2-dihydropyridin-1-yl)thiourea

C16H18N4OS (314.1201)

1,1-(2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-diyl)diethanone

C17H18N2O4 (314.1267)

ZINC159409

C16H18N4OS (314.1201)

6-(4-sulfophenyl)nonanoic acid

C15H22O5S (314.1188)

8-(4-sulfophenyl)nonanoic acid

C15H22O5S (314.1188)

8alpha-hydroxy-10-deoxycyclomerrillianolide

C15H22O7 (314.1365)

neodunnianin

C15H22O7 (314.1365)

1alpha,2alpha,3alpha,4alpha,10alpha-Pentahydroxyguaia-11(13)ene-12,6alpha-olide

C15H22O7 (314.1365)

beta-D-1C-(1S,2R,3R,4S,1,2,3,4,5-pentahydroxypentyl)glucopyranoside|diospyrodin

beta-D-1C-(1S*,2R*,3R*,4S*,1,2,3,4,5-pentahydroxypentyl)glucopyranoside|diospyrodin

C11H22O10 (314.1213)

1-(4-hydroxyphenyl)-2-propanol 4-O-beta-D-glucopyranoside

C15H22O7 (314.1365)

10??-Hydroxypseudoanisatin

C15H22O7 (314.1365)

10??-Hydroxycyclopseudoanisatin

C15H22O7 (314.1365)

(2S,3R,3aR,4R,4S,5R,7R,8aR)-octahydro-3,4-dihydroxy-3-(hydroxymethyl)-5-methyl-3H-spiro[4,7-methanofuro[3,2-c]oxepine-2,2-pyran]-6(4H)-one|glochicoccin A

C15H22O7 (314.1365)

2-O-beta-D-galactofuranosyl-D-arabinitol|O2-beta-D-Galactofuranosyl-D-arabit|O2-beta-D-galactofuranosyl-D-arabitol

C11H22O10 (314.1213)

Gramilaurone

C15H22O7 (314.1365)

1alpha-hydroxypseudoanisatin|1??-Hydroxypseudoanisatin

C15H22O7 (314.1365)

Amoenin

C15H22O7 (314.1365)

Dimethyl (methylenebis(4,1-phenylene))dicarbamate

C17H18N2O4 (314.1267)

1-(4-methoxy-2,5-dimethylphenyl)-beta-D-glucopyranose|dunnianoside H

C15H22O7 (314.1365)

C15H22O7

C15H22O7 (314.1365)

grevilloside G

C15H22O7 (314.1365)

2-alpha-D-glucosylribitol

C11H22O10 (314.1213)

1,13,14-trihydroxy-3,4-anhydrofloridanolide|dunnianolide B

C15H22O7 (314.1365)

(11)7,14-ortholactone of 14-hydroxy-3-oxofloridanolide

C15H22O7 (314.1365)

merrillianolide

C15H22O7 (314.1365)

11,13-dihydro-15-carboxyelemane

C15H22O7 (314.1365)

2alpha-hydroxycycloparviflorolide

C15H22O7 (314.1365)

cyclomerrillianolide

C15H22O7 (314.1365)

1-O-beta-D-Galactopyranosyl-D-ribitol

C11H22O10 (314.1213)

Penicillin DF

C14H22N2O4S (314.13)

SPA-9C (TENTATIVE)

C15H22O5S (314.1188)

TENTATIVELY IDENTIFIED SPECTRUM ONLY!!!!!!!!!; Extracted (without noise removal) from ZUE_N: mz313_11_rt10_56_HCD60_SPA-9C; CONFIDENCE Tentative identification: isomers possible (Level 3); Good match to 6phiC9SPC, LIT00035

8phiC9SPC

C15H22O5S (314.1188)

Literature spectrum; CONFIDENCE Identification confirmed with Reference Standard (Level 1); Digitised from figure: approximate intensities

6phiC9SPC

C15H22O5S (314.1188)

Literature spectrum; CONFIDENCE Identification confirmed with Reference Standard (Level 1); Digitised from figure: approximate intensities

TiaprideMet

C14H22N2O4S (314.13)

trimethylene bis(4-aminobenzoate)

Propane-1,3-diyl bis(4-aminobenzoate)

C17H18N2O4 (314.1267)

CONFIDENCE standard compound; INTERNAL_ID 291; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7854; ORIGINAL_PRECURSOR_SCAN_NO 7850 CONFIDENCE standard compound; INTERNAL_ID 291; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7867; ORIGINAL_PRECURSOR_SCAN_NO 7864 CONFIDENCE standard compound; INTERNAL_ID 291; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7905; ORIGINAL_PRECURSOR_SCAN_NO 7903 CONFIDENCE standard compound; INTERNAL_ID 291; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7898; ORIGINAL_PRECURSOR_SCAN_NO 7895 CONFIDENCE standard compound; INTERNAL_ID 291; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7906; ORIGINAL_PRECURSOR_SCAN_NO 7902

1,2,4-triphenylbutane-1,4-dione

C22H18O2 (314.1307)

(R,R)-(+)-1,2-DI(1-NAPHTHYL)-1,2-ETHANEDIOL

C22H18O2 (314.1307)

2-[4-(2-Pyridinyl)phenyl]-1H-benzimidazole-4-carboxamide

C19H14N4O (314.1168)

4-(2-Boc-amino-pyridin-4-yl)-benzoic acid

C17H18N2O4 (314.1267)

N-Fmoc-L-Alanine-3,3,3-D3

C18H14D3NO4 (314.1346)

N1,N3-BIS(2-METHOXYPHENYL)MALONAMIDE

C17H18N2O4 (314.1267)

2-[[2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetyl]amino]acetic acid

C17H18N2O4 (314.1267)

4-[(4-METHYL-BENZYLAMINO)-METHYL]-3-NITRO-BENZOICACIDMETHYLESTER

C17H18N2O4 (314.1267)

(S S)-(-)-1-(1-NAPHTHYL)-2-(2-NAPHTHYL)&

C22H18O2 (314.1307)

(3-((2-Morpholinoethyl)carbamoyl)phenyl)boronic acid hydrochloride

C13H20BClN2O4 (314.1205)

1-(4-methoxyphenyl)-2,3,4,9-tetrahydro-1H-beta-carboline hydrochloride

C18H19ClN2O (314.1186)

2-((tert-Butyldiphenylsilyl)oxy)acetic acid

C18H22O3Si (314.1338)

(S,S)-(-)-1,2-DI(1-NAPHTHYL)-1,2-ETHANEDIOL

C22H18O2 (314.1307)

6,6?ˉ-DIMETHYL-1,1?ˉ-BI-2-NAPHTHOL

C22H18O2 (314.1307)

4-(1-Phenyl-1H-benzimidazol-2-yl)phenylboronic acid

C19H15BN2O2 (314.1227)

2-(4-((TERT-BUTOXYCARBONYL)AMINO)PHENYL)NICOTINIC ACID

C17H18N2O4 (314.1267)

phenmedipham-ethyl

C17H18N2O4 (314.1267)

Methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate

DMCM hydrochloride,4-Ethyl-6,7-dimethoxy-9H-pyrido[3,4-b]indole-3-carboxylicacidmethylesterhydrochloride

C17H18N2O4 (314.1267)

D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D003292 - Convulsants

[4-(2-Phenyl-1H-benzimidazol-1-yl)phenyl]-boronic acid

C19H15BN2O2 (314.1227)

(3-(4-(2-Hydroxyethyl)piperazine-1-carbonyl)phenyl)boronic acid hydrochloride

C13H20BClN2O4 (314.1205)

1-Propanol,2-[(tetrahydro-2H-pyran-2-yl)oxy]-,4-methylbenzenesulfonate,(2S)-

C15H22O5S (314.1188)

2-[4-(4-chlorophenyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C18H20BClO2 (314.1245)

Lorcinadol

C17H19ClN4 (314.1298)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

6,7-dimethoxy-1-(4-nitrophenyl)-1,2,3,4-tetrahydroisoquinoline

C17H18N2O4 (314.1267)

3-(1-phenyl-1H-benzo[d]iMidazol-2-yl)phenylboronic acid

C19H15BN2O2 (314.1227)

Molidustat

C13H14N8O2 (314.124)

C471 - Enzyme Inhibitor Molidustat (BAY 85-3934) is a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase (HIF-PH) with mean IC50 values of 480 nM for PHD1, 280 nM for PHD2, and 450 nM for PHD3.

(E)-3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-2-propenenitrile

C21H15FN2 (314.1219)

Bis-PEG5-thiol

C12H26O5S2 (314.1222)

2,2-Dimethoxy-1,1-binaphthalen

C22H18O2 (314.1307)

4-benzhydrylpiperazine-1-carbonyl chloride

C18H19ClN2O (314.1186)

(R,R)-(+)-1-(1-Naphthyl)-2-(2-naphthyl)-1,2-ethanediol

C22H18O2 (314.1307)

Cobimetinib intermediate7

C15H17F3N2O2 (314.1242)

2-(1,3-b

C16H18N4OS (314.1201)

4-Chloro-2-fluoro-5-propoxyphenylboronic acid, pinacol ester

C15H21BClFO3 (314.1256)

2-(4-Chloro-2-fluoro-5-isopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C15H21BClFO3 (314.1256)

3-(4-((TERT-BUTOXYCARBONYL)AMINO)PHENYL)PICOLINIC ACID

C17H18N2O4 (314.1267)

1,1-Binaphthalene, 2,2-dimethoxy-, (±)-

C22H18O2 (314.1307)

4-[4-(2-Hydroxyethyl)-1-piperazinylcarbonyl]benzeneboronic acid

C13H20BClN2O4 (314.1205)

METHYL 6-(4-METHOXYPHENYLAMINO)-5-OXO-1,2,3,5-TETRAHYDROINDOLIZINE-8-CARBOXYLIATE

C17H18N2O4 (314.1267)

1,2-Hydrazinedicarboxylicacid, 1-methyl-, 1,2-bis(phenylmethyl) ester

C17H18N2O4 (314.1267)

1H-Imidazole-5-carboxylic acid, 1-((1R)-1-phenylethyl)-, 1-(methoxycarbonyl)cyclopropyl ester

C17H18N2O4 (314.1267)

D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018755 - GABA Agonists

Dimethyl 5,5-methylenedianthranilate

C17H18N2O4 (314.1267)

N-cyclopentyl-2-[[6-(2-pyridinyl)-3-pyridazinyl]thio]acetamide

C16H18N4OS (314.1201)

1,4-Dimethoxy-9-phenylanthracene

C22H18O2 (314.1307)

N-[2-(Diethylamino)ethyl]-2-hydroxy-5-(methylsulfonyl)benzamide (Desmethyltiapride)

C14H22N2O4S (314.13)

2-Hydroxy-5-{[(1E)-2-phenylethylidene]amino}-L-tyrosine

C17H18N2O4 (314.1267)

8-Methyl-8-(4-sulfophenyl)octanoic acid

C15H22O5S (314.1188)

Huprine W

C18H19ClN2O (314.1186)

1-[[Oxo(3-pyridinyl)methyl]amino]-3-(4-propan-2-ylphenyl)thiourea

C16H18N4OS (314.1201)

N-[(E)-[4-(4-Fluoroanilino)-4-oxobutan-2-ylidene]amino]pyridine-2-carboxamide

C16H15FN4O2 (314.1179)

1-(2,5-Dimethoxyphenyl)sulfonyl-4-ethylpiperazine

C14H22N2O4S (314.13)

N-[2-[(phenylmethyl)amino]-1,3-benzodioxol-2-yl]carbamic acid ethyl ester

C17H18N2O4 (314.1267)

3-(2-fluorophenyl)-2-(4-fluorophenyl)-5,6,7,7a-tetrahydro-3H-pyrrolo[1,2-c]imidazol-1-one

C18H16F2N2O (314.1231)

1-[[2-(3-Methylanilino)-1-oxoethyl]amino]-3-phenylthiourea

C16H18N4OS (314.1201)

N-[2-(1-naphthalenyloxy)-1-oxoethyl]-2-oxolanecarbohydrazide

C17H18N2O4 (314.1267)

(7-Methoxy-4,5-dihydrobenzo[g][1,2]benzoxazol-3-yl)-(4-morpholinyl)methanone

C17H18N2O4 (314.1267)

1,4-dideoxy-1-({2,6-dioxo-5-[(E)-(2-oxopropylidene)amino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-erythro-pentitol

C12H18N4O6 (314.1226)

6-(butan-2-ylthio)-1-(4-methylphenyl)-2H-pyrazolo[3,4-d]pyrimidin-4-one

C16H18N4OS (314.1201)

N-(3-O-phospho-D-ribulosyl)-cadaverine

C10H23N2O7P (314.1243)

3-{(3E)-4-hydroxy-6-oxo-3-[(2-phenylethyl)imino]cyclohexa-1,4-dien-1-yl}-L-alanine

C17H18N2O4 (314.1267)

A non-proteinogenic L-alpha-amino acid obtained by formal condensation of the 3-oxo group of L-topaquinone with the amino group of 2-phenylethylamine.

1,2-dideoxy-1-({2,6-dioxo-5-[(E)-(2-oxopropylidene)amino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-erythro-pentitol

C12H18N4O6 (314.1226)

[(1S,2aS,8bS)-2-[(2-chlorophenyl)methyl]-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C18H19ClN2O (314.1186)

[(1R,2aR,8bR)-2-[(2-chlorophenyl)methyl]-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C18H19ClN2O (314.1186)

[(1S,2aR,8bR)-2-[(2-chlorophenyl)methyl]-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C18H19ClN2O (314.1186)

[(1R,2aS,8bS)-2-[(2-chlorophenyl)methyl]-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C18H19ClN2O (314.1186)

5-D-5-OP-RU

C12H18N4O6 (314.1226)

2-(3,4-dichlorophenyl)-N-methyl-N-[(1-methylpiperidin-2-yl)methyl]ethanamine

C16H24Cl2N2 (314.1316)

[(3R,4R)-1-(5-aminopentylamino)-4,5-dihydroxy-2-oxopentan-3-yl] dihydrogen phosphate

C10H23N2O7P (314.1243)

2-hydroxy-5-[(1E)-(2-phenylethylidene)amino]-L-tyrosine

C17H18N2O4 (314.1267)

An imine that is L-tyrosine bearing an additional hydroxy substituent at position 2 as well as a (2-phenylethylidene)amino substituent at position 5.

2-[(1r,2s,4s,5r,6r)-5-[(1s)-1-carboxy-1-hydroxyethyl]-2-ethenyl-4,6-dihydroxy-2-methylcyclohexyl]prop-2-enoic acid

C15H22O7 (314.1365)

9h-pyrido[3,4-b]indole-3-carboxylic acid; methyl isobutyrate

C17H18N2O4 (314.1267)

3a-chloro-2-(2-hydroxypropan-2-yl)-6-(3-methylbuta-1,3-dien-1-ylidene)-hexahydro-1-benzofuran-4,5-diol

C16H23ClO4 (314.1285)

4-{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy}pentane-1,2,3,5-tetrol

C11H22O10 (314.1213)

(2s,3s,4r)-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentane-1,2,3,5-tetrol

C11H22O10 (314.1213)

(1s,2r,6s,7r,8s,10r,13r)-2,7,8-trihydroxy-6-(hydroxymethyl)-7,13-dimethyl-4,9-dioxatetracyclo[6.5.1.0¹,¹⁰.0⁶,¹⁰]tetradecan-3-one

C15H22O7 (314.1365)

(2s,3r,4s,5s,6r)-2-{2-[(1s)-1-hydroxyethyl]-3-methylphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H22O7 (314.1365)

(3as,6r,6ar,7r,8s,9r,9as,9bs)-6,6a,7,8,9-pentahydroxy-6,9-dimethyl-3-methylidene-hexahydro-3ah-azuleno[4,5-b]furan-2-one

C15H22O7 (314.1365)

4,12,13-trihydroxy-9-(hydroxymethyl)-6,10-dimethyl-3,14-dioxatetracyclo[6.5.1.0¹,¹⁰.0⁴,⁹]tetradecan-5-one

C15H22O7 (314.1365)

1-(4-hydroxyphenyl)-2-propanol

C15H22O7 (314.1365)

{"Ingredient_id": "HBIN001504","Ingredient_name": "1-(4-hydroxyphenyl)-2-propanol","Alias": "NA","Ingredient_formula": "C15H22O7","Ingredient_Smile": "NA","Ingredient_weight": "314.335","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9667","PubChem_id": "NA","DrugBank_id": "NA"}

1α-hydroxypseudoanisatin

C15H22O7 (314.1365)

{"Ingredient_id": "HBIN002310","Ingredient_name": "1\u03b1-hydroxypseudoanisatin","Alias": "NA","Ingredient_formula": "C15H22O7","Ingredient_Smile": "CC1(CC(C2(C13CC(=O)C(C2(COC(=O)C3)C)(C)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10667","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(1r,2s,4r,9r,11s,12r,13r)-2,11,12-trihydroxy-13-(hydroxymethyl)-12,13-dimethyl-6,14-dioxatetracyclo[9.2.1.0¹,⁹.0⁴,⁹]tetradecan-7-one

C15H22O7 (314.1365)

(1s,4s,6s,8s,9r,10s,12r,13s)-4,12,13-trihydroxy-9-(hydroxymethyl)-6,10-dimethyl-3,14-dioxatetracyclo[6.5.1.0¹,¹⁰.0⁴,⁹]tetradecan-5-one

C15H22O7 (314.1365)

(1's,2s,2'r,3's,4'r,7'r,9'r,10'r,11's)-2'-(hydroxymethyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-ene-3',4',10',11'-tetrol

C15H22O7 (314.1365)

2-(hydroxymethyl)-6-[4-(2-hydroxypropyl)phenoxy]oxane-3,4,5-triol

C15H22O7 (314.1365)

1,3-bis(1,8-naphthyridin-2-yl)propan-2-one

C19H14N4O (314.1168)

(1r,2r,5r,6s,8r,10r,13r,14r)-2,10,13,14-tetrahydroxy-1,5,13-trimethyl-9,11-dioxatetracyclo[6.4.1.1⁶,¹⁰.0²,⁶]tetradecan-3-one

C15H22O7 (314.1365)